In 2012, there were over 1.5 million botulinum toxin A injections in Europe, almost a double-digit increase over the previous year.
Vancouver, BC (PRWEB) May 21, 2013
According to a new report series by iData Research, the total European market for cosmetic surgery, facial aesthetics and medical laser devices is valued at €869.4 million.This market includes botulinum toxin A, dermal fillers, breast implants, non-breast implants, aesthetic lasers and light devices, non-invasive skin tightening devices, and non-invasive fat reduction devices. Of those, the largest segment is the botulinum toxin A segment. Growth in this market is primarily driven by significant demand and brand recognition.
The report covers 15 European countries for which brand recognition is a key driver within all market segments. Furthermore, this aging population is trending toward choices for affordability and minimally invasive products such as laser and light therapy devices. In 2012, the fastest growing segments in this market were the botulinum toxin A, the non-invasive skin tightening and the breast implant segments; all with rising growth rates. “In particular, the market for aesthetic botulinum toxin will continue to increase at a double digit CAGR over the next few years,” says Dr. Kamran Zamanian, CEO of iData.
Countries with younger populations tend to perform more aesthetic procedures than those with older populations. In 2012, there were over 1.5 million botulinum toxin A injections in Europe, almost a double-digit increase over the previous year. The total number of injections included botulinum toxin A injections used for aesthetic and therapeutic indications. Prior to the recession, Spain and Italy were two of the largest markets for cosmetic surgeries in Europe, with the highest demand for cosmetic surgery devices. Additionally, Italy has approximately 1,500 plastic surgeons; the country is ranked in the top 5 countries in the world for plastic surgeon density. Despite the European economy and the decrease in demand, procedure numbers remain higher in Italy compared to the rest of the European countries.
Allergan leads the European market for cosmetic surgery, facial aesthetics and medical lasers with almost half of the total market share. The company has a strong lead in the botulinum toxin A segment with nearly three quarters of this segments’ market share. Mentor Worldwide LLC is the second leading competitor in Europe. Mentor is better known for their presence in the breast augmentation implants and dermal filler markets. Other companies included in the report are Galderma, Zeltiq Aesthetics, Inc., Solta Medical, Cynosure, Syneron/Candela, Alma Laser, Palomar, Merz Pharmaceutical, Lumenis, Asclepion, Inc. Hironic Co, Ltd, DEKA Laser, Laboratoires Teoxane, Cutera, Inc., Ulthera, Inc., POLYTECH Health & Aesthetics, Silimed, Medicor and Anteis.
A free report synopsis of the Market for Cosmetic Surgery, Facial Aesthetics and Medical Lasers is available for the U.S. and Europe (Germany, France, United Kingdom, Italy, Spain, Benelux, Scandinavia, Austria, Switzerland, and Portugal). These reports contain comprehensive analysis including procedure numbers, units sold, market value, forecasts, as well as a detailed competitive breakdown. Other markets analyzed include botulinum toxin A market, dermal filler market, breast augmentation and reconstruction implant market, non-breast augmentation and reconstruction implant market, aesthetic laser and light therapy device market, non-invasive skin tightening device market and non-invasive fat reduction device market.
About iData Research
iData Research is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: women’s health, imaging, video endoscopy, laparoscopy, soft tissue repair, ENT and more.